Synuclein in neurodegeneration
- 1 January 2021
- book chapter
- Published by Elsevier
- Vol. 103, 97-134
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseaseScientific Reports, 2013
- Genetic players in multiple system atrophy: unfolding the nature of the beastNeurobiology of Aging, 2011
- Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in VitroJournal of Biological Chemistry, 2011
- α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in VitroScience, 2010
- Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating diseaseMolecular and Cellular Neuroscience, 2006
- Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseThe FASEB Journal, 2006
- Differential Expression and Distribution of α-, β-, and γ-Synuclein in the Developing Human Substantia NigraExperimental Neurology, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Regularly Occurring Periods of Eye Motility, and Concomitant Phenomena, During SleepScience, 1953